Mahamaya Lifesciences Limited (BOM:544611)
178.35
+2.35 (1.34%)
At close: Sep 4, 2026
| Market Cap | 4.17B |
| Revenue (ttm) | 3.29B +24.5% |
| Net Income | 165.23M +29.0% |
| EPS | 8.33 +10.4% |
| Shares Out | 23.41M |
| PE Ratio | 21.41 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,200 |
| Open | 183.95 |
| Previous Close | 176.00 |
| Day's Range | 176.75 - 184.00 |
| 52-Week Range | 111.00 - 205.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 8, 2026 |